| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant immunotherapy: the sting in the tail
|
Higham, Claire E.
|
|
|
132 |
C |
p. 207-210
|
artikel
|
| 2 |
An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non–small-cell lung cancer
|
Tsakonas, Georgios
|
|
|
132 |
C |
p. 24-34
|
artikel
|
| 3 |
A patient reported outcome platform, a useful tool to improve monitoring and effective management of Covid-19–positive patients with cancer
|
Scotté, Florian
|
|
|
132 |
C |
p. 1-4
|
artikel
|
| 4 |
Association between immune-related adverse events and long-term survival outcomes in patients treated with immune checkpoint inhibitors
|
Maillet, Denis
|
|
|
132 |
C |
p. 61-70
|
artikel
|
| 5 |
Association of premenopausal risk-reducing salpingo-oophorectomy with breast cancer risk in BRCA1/2 mutation carriers: Maximising bias-reduction
|
Stjepanovic, Neda
|
|
|
132 |
C |
p. 53-60
|
artikel
|
| 6 |
Cancer and coronavirus disease 2019; how do we manage cancer optimally through a public health crisis?
|
Vrdoljak, Eduard
|
|
|
132 |
C |
p. 98-99
|
artikel
|
| 7 |
Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–related disease pandemic
|
Tarantino, Paolo
|
|
|
132 |
C |
p. 8-10
|
artikel
|
| 8 |
COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors
|
Leonetti, Alessandro
|
|
|
132 |
C |
p. 122-124
|
artikel
|
| 9 |
2-deoxy-2[F-18] fluoro-D-glucose positron emission tomography Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma
|
Picardi, M.
|
|
|
132 |
C |
p. 85-97
|
artikel
|
| 10 |
Differences in disease status between patients with progression after first-line chemotherapy versus early relapse after adjuvant chemotherapy who undergo second-line chemotherapy for gastric cancer: Exploratory analysis of the randomized phase III TRICS trial
|
Nishikawa, Kazuhiro
|
|
|
132 |
C |
p. 159-167
|
artikel
|
| 11 |
Direct-to-consumer misleading information on cancer risks calls for an urgent clarification of health genetic testing performed by commercial companies
|
de Pauw, Antoine
|
|
|
132 |
C |
p. 100-103
|
artikel
|
| 12 |
Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)
|
Singer, Christian F.
|
|
|
132 |
C |
p. 43-52
|
artikel
|
| 13 |
Fatal association of fulminant myocarditis and rhabdomyolysis after immune checkpoint blockade
|
Tomoaia, Raluca
|
|
|
132 |
C |
p. 224-227
|
artikel
|
| 14 |
Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment
|
Hrusak, Ondrej
|
|
|
132 |
C |
p. 11-16
|
artikel
|
| 15 |
Genomic analysis in short- and long-term patients with malignant pleura mesothelioma treated with palliative chemotherapy
|
Torricelli, Federica
|
|
|
132 |
C |
p. 104-111
|
artikel
|
| 16 |
How to determine kidney function in cancer patients?
|
Sprangers, Ben
|
|
|
132 |
C |
p. 141-149
|
artikel
|
| 17 |
Human chorionic gonadotropin–positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3)
|
Seidel, Christoph
|
|
|
132 |
C |
p. 127-135
|
artikel
|
| 18 |
Immune checkpoint inhibitor use and tuberculosis: a systematic review of the literature
|
Zaemes, Jacob
|
|
|
132 |
C |
p. 168-175
|
artikel
|
| 19 |
Indirect treatment comparison of nivolumab versus placebo for the adjuvant treatment of melanoma
|
Hemstock, Matthew
|
|
|
132 |
C |
p. 176-186
|
artikel
|
| 20 |
Lessons from the coronavirus disease 2019 pandemic: Will virtual patient management reshape uro-oncology in Germany?
|
Rodler, Severin
|
|
|
132 |
C |
p. 136-140
|
artikel
|
| 21 |
Managing patients with cancer in the COVID-19 era
|
Peng, Ling
|
|
|
132 |
C |
p. 5-7
|
artikel
|
| 22 |
Molecular mechanisms of resistance to BRAF and MEK inhibitors in BRAF V600E non–small cell lung cancer
|
Facchinetti, Francesco
|
|
|
132 |
C |
p. 211-223
|
artikel
|
| 23 |
Outstanding clinical efficacy of PD-1/PD-L1 inhibitors for pulmonary pleomorphic carcinoma
|
Lee, Jiyun
|
|
|
132 |
C |
p. 150-158
|
artikel
|
| 24 |
Patients with cancer in the era of 2019 novel coronavirus disease
|
Hartemink, Koen J.
|
|
|
132 |
C |
p. 125-126
|
artikel
|
| 25 |
Phase I expansion cohort to evaluate the combination of bevacizumab, sorafenib and low-dose cyclophosphamide in children and young adults with refractory or recurrent solid tumours
|
Federico, Sara M.
|
|
|
132 |
C |
p. 35-42
|
artikel
|
| 26 |
Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinoma
|
O'Reilly, Eileen M.
|
|
|
132 |
C |
p. 112-121
|
artikel
|
| 27 |
Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey
|
Indini, Alice
|
|
|
132 |
C |
p. 17-23
|
artikel
|
| 28 |
Systemic treatment of brain metastases in non-small cell lung cancer
|
Page, Simon
|
|
|
132 |
C |
p. 187-198
|
artikel
|
| 29 |
The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region
|
Trapani, Dario
|
|
|
132 |
C |
p. 199-206
|
artikel
|
| 30 |
The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis
|
Orhan, Adile
|
|
|
132 |
C |
p. 71-84
|
artikel
|
Tijdschrift beschrijving